Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > CFRX ContraFect > Detailed Quotes

CFRX ContraFect

Watchlist
0.067
-0.003-4.29%
Close  02/07 16:00 ET
0.067
-0.000-0.45%
Pre Mkt Price 02/08 07:45 ET
High
0.070
Open
0.070
Turnover
564.49K
Low
0.064
Pre Close
0.070
Volume
8.47M
Market Cap
2.94M
P/E(TTM)
Loss
52wk High
4.540
Shares
43.68M
P/E(Static)
Loss
52wk Low
0.059
Float Cap
2.47M
Bid/Ask %
-68.85%
Historical High
62.400
Shs Float
36.67M
Volume Ratio
0.31
Historical Low
0.059
Dividend TTM
--
Div Yield TTM
--
P/B
-0.95
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
23.09%
Amplitude
9.14%
Avg Price
0.066
Lot Size
1
Float Cap
2.47M
Bid/Ask %
-68.85%
Historical High
62.400
Shs Float
36.67M
Volume Ratio
0.31
Historical Low
0.059
Dividend TTM
--
P/B
-0.95
Dividend LFY
--
Turnover Ratio
23.09%
Amplitude
9.14%
Avg Price
0.066
Lot Size
1
Price Forecast

News

Comment

Company Overview More
ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.
CEO: Dr. Roger J. Pomerantz, F.A.C.P.,M.D.
Market: NASDAQ
Listing Date: 07/29/2014
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist